UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 137

Sortiert nach

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

The American journal of gastroenterology, 2021-04, Vol.116 (4), p.723-732

2021

Link zum Volltext

Verfügbarkeit prüfen

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

Journal of hepatology, 2016-10, Vol.65 (4), p.692-699

2016

Link zum Volltext

Verfügbarkeit prüfen

The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test

PloS one, 2016-02, Vol.11 (2), p.e0149230-e0149230

2016

Link zum Volltext

Verfügbarkeit prüfen

Sedation in Screening Colonoscopy: Impact on Quality Indicators And Complications

The American journal of gastroenterology, 2012-12, Vol.107 (12), p.1837-1848

2012

Link zum Volltext

Verfügbarkeit prüfen

Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)

Wiener Klinische Wochenschrift, 2017-11, Vol.129 (Suppl 3), p.135-158

2017

Link zum Volltext

Verfügbarkeit prüfen

Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites

PloS one, 2014-11, Vol.9 (11), p.e110503

2014

Link zum Volltext

Verfügbarkeit prüfen

The impact of hepatic steatosis on portal hypertension

PloS one, 2019-11, Vol.14 (11), p.e0224506-e0224506

2019

Link zum Volltext

Verfügbarkeit prüfen

Chylous Ascites as the Main Clinical Symptom of a Strongyloides stercoralis Infection in an Immigrant from Bosnia-Herzegovina

European journal of case reports in internal medicine, 2022, Vol.9 (11), p.003603-003603

2022

Link zum Volltext

Verfügbarkeit prüfen

von Willebrand Factor Antigen Predicts Outcomes in Patients after Liver Resection of Hepatocellular Carcinoma

Gut and Liver, 2020, 14(2), , pp.218-224

2020

Link zum Volltext

Verfügbarkeit prüfen

Evolution of SARS-CoV-2 Key Mutations in Vienna Detected by Large Scale Screening Program

Viruses, 2021-10, Vol.13 (10), p.2014

2021

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function

Wiener Klinische Wochenschrift, 2018-07, Vol.130 (13-14), p.446-455

2018

Link zum Volltext

Verfügbarkeit prüfen

Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience

PloS one, 2018, Vol.13 (1), p.e0189414-e0189414

2018

Link zum Volltext

Verfügbarkeit prüfen

Noninvasive screening for liver fibrosis and portal hypertension by transient elastography—a large single center experience

Wiener Klinische Wochenschrift, 2012-06, Vol.124 (11-12), p.395-402

2012

Link zum Volltext

Verfügbarkeit prüfen

Alcohol‐related liver disease phenotype impacts survival after an acute variceal bleeding episode

Liver international, 2023-07, Vol.43 (7), p.1548-1557

2023

Link zum Volltext

Verfügbarkeit prüfen

Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice

Digestive and liver disease, 2017-12, Vol.49 (12), p.1360-1367

2017

Link zum Volltext

Verfügbarkeit prüfen

Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosis

Hepatology research, 2019-02, Vol.49 (2), p.201-211

2019

Link zum Volltext

Verfügbarkeit prüfen

Endoscopic imaging of the vermiform appendix (with video)

Gastrointestinal endoscopy, 2014-12, Vol.80 (6), p.1156-1160

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of restrictions due to COVID-19 on a quality-assured screening colonoscopy program

Endoscopy International Open, 2021-09, Vol.9 (9), p.E1315-E1320

2021

Link zum Volltext

Verfügbarkeit prüfen

Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis

Gastroenterology (New York, N.Y. 1943), 2014-06, Vol.146 (7), p.1680-1690.e1

2014

Link zum Volltext

Verfügbarkeit prüfen

Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol

Gut, 2013-11, Vol.62 (11), p.1634-1641

2013

Link zum Volltext

Verfügbarkeit prüfen

Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis

Hepatology (Baltimore, Md.), 2012-10, Vol.56 (4), p.1439-1447

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of adenomas per colonoscopy and adenomas per positive participant as new quality parameters in screening colonoscopy

Gastrointestinal endoscopy, 2019-03, Vol.89 (3), p.496-502

2019

Link zum Volltext

Verfügbarkeit prüfen

Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis

Journal of hepatology, 2013-05, Vol.58 (5), p.911-921

2013

Link zum Volltext

Verfügbarkeit prüfen

Diagnostik- und Therapieleitfaden 2023 für PBC in Österreich: Primär biliäre Cholangitis frühzeitig erkennen und risikostratifiziert behandeln

Journal für gastroenterologische und hepatologische Erkrankungen, 2023-04, Vol.21 (1), p.21-25

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of adenoma detection rate on detection of advanced adenomas and endoscopic adverse events in a study of over 200,000 screening colonoscopies

Gastrointestinal endoscopy, 2020-01, Vol.91 (1), p.135-141

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(127)

Publikationsform

Artikel
(137)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test

Sedation in Screening Colonoscopy: Impact on Quality Indicators And Complications

Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)

Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites

The impact of hepatic steatosis on portal hypertension

Chylous Ascites as the Main Clinical Symptom of a Strongyloides stercoralis Infection in an Immigrant from Bosnia-Herzegovina

von Willebrand Factor Antigen Predicts Outcomes in Patients after Liver Resection of Hepatocellular Carcinoma

Evolution of SARS-CoV-2 Key Mutations in Vienna Detected by Large Scale Screening Program

Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function

Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience

Noninvasive screening for liver fibrosis and portal hypertension by transient elastography—a large single center experience

Alcohol‐related liver disease phenotype impacts survival after an acute variceal bleeding episode

Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice

Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosis

Endoscopic imaging of the vermiform appendix (with video)

Impact of restrictions due to COVID-19 on a quality-assured screening colonoscopy program

Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis

Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol

Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis

Evaluation of adenomas per colonoscopy and adenomas per positive participant as new quality parameters in screening colonoscopy

Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis

Diagnostik- und Therapieleitfaden 2023 für PBC in Österreich: Primär biliäre Cholangitis frühzeitig erkennen und risikostratifiziert behandeln

Impact of adenoma detection rate on detection of advanced adenomas and endoscopic adverse events in a study of over 200,000 screening colonoscopies

Suchergebnisse filtern